399 related articles for article (PubMed ID: 29803225)
21. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
22. Evidence of functional duplicity of Nestin expression in the adult mouse midbrain.
Farzanehfar P; Lu SS; Dey A; Musiienko D; Baagil H; Horne MK; Aumann TD
Stem Cell Res; 2017 Mar; 19():82-93. PubMed ID: 28088038
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
[TBL] [Abstract][Full Text] [Related]
24. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
[TBL] [Abstract][Full Text] [Related]
25. Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo.
Stayte S; Rentsch P; Tröscher AR; Bamberger M; Li KM; Vissel B
PLoS One; 2017; 12(1):e0167211. PubMed ID: 28121982
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
27. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
[TBL] [Abstract][Full Text] [Related]
29. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
Yadav SK; Pandey S; Singh B
J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
[TBL] [Abstract][Full Text] [Related]
30. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
[TBL] [Abstract][Full Text] [Related]
31. Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.
Hsieh MH; Meng WY; Liao WC; Weng JC; Li HH; Su HL; Lin CL; Hung CS; Ho YJ
Brain Res Bull; 2017 Jun; 132():129-138. PubMed ID: 28576659
[TBL] [Abstract][Full Text] [Related]
32. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
34. Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice.
Crupi R; Cambiaghi M; Spatz L; Hen R; Thorn M; Friedman E; Vita G; Battaglia F
Biol Psychiatry; 2010 Mar; 67(6):558-66. PubMed ID: 20185032
[TBL] [Abstract][Full Text] [Related]
35. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.
Marxreiter F; Ettle B; May VE; Esmer H; Patrick C; Kragh CL; Klucken J; Winner B; Riess O; Winkler J; Masliah E; Nuber S
Neurobiol Dis; 2013 Nov; 59():38-51. PubMed ID: 23867236
[TBL] [Abstract][Full Text] [Related]
36. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.
Depboylu C; Stricker S; Ghobril JP; Oertel WH; Priller J; Höglinger GU
Exp Neurol; 2012 Dec; 238(2):183-91. PubMed ID: 22964486
[TBL] [Abstract][Full Text] [Related]
37. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
Pattarini R; Smeyne RJ; Morgan JI
Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
[TBL] [Abstract][Full Text] [Related]
38. miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction.
Woodbury ME; Freilich RW; Cheng CJ; Asai H; Ikezu S; Boucher JD; Slack F; Ikezu T
J Neurosci; 2015 Jul; 35(26):9764-81. PubMed ID: 26134658
[TBL] [Abstract][Full Text] [Related]
39. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
40. Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Peng J; Andersen JK
Aging Cell; 2011 Apr; 10(2):255-62. PubMed ID: 21108729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]